India Pharma Outlook Team | Thursday, 28 August 2025
The largest consumer electronics company in India, Samsung, has announced the arrival of its next-generation mobile CT product line in India in partnership with NeuroLogica, a division of Samsung Electronics Co., Ltd. One of the world's leading companies in cutting-edge medical imaging technology is Samsung Electronics Co., Ltd.
These next-generation devices, which are specifically made to revolutionize diagnostic with technological innovation and interventional radiology in India, combine patient-first design, mobility, and AI-powered efficiency to enable healthcare providers to give high-quality care whenever and wherever they are needed.
The new offerings are all aptly labelled CereTom Elite, OmniTom Elite, OmniTom Elite PCD, and BodyTom 32/64 - all products to meet the varied clinical requirements of hospitals and specialty centres. Samsung is going to now help democratise access to advanced imaging in India by enabling adoption across hospitals of all shapes and sizes, even in the most underserved areas.
Also Read: Hyderabad Emerges as Hub for Biotech, Pharma and MedTech, says Revanth Reddy
“Samsung is taking a decisive step toward making advanced medical imaging more accessible, efficient, and patient-centric with the launch of the mobile CT solutions in India. These innovations are as much about technology as they are about empowering healthcare providers to bridge the care gap between metros and tier-2/3 cities. We believe this portfolio will strengthen India’s healthcare infrastructure, support clinical results across specialties, and play a crucial role in improving patient outcomes at scale,” said Atantra Das Gupta, head of HME business, Samsung India.
